Angiomyolipoma
Showing 26 - 50 of 74
Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM) Trial in Worldwide (Everolimus (RAD001), Everolimus Placebo)
Completed
- Tuberous Sclerosis Complex (TSC)
- Lymphangioleiomyomatosis (LAM)
- Everolimus (RAD001)
- Everolimus Placebo
-
Birmingham, Alabama
- +24 more
Jan 3, 2017
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) Trial in Worldwide (Epanova®
Completed
- Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
- Epanova® (omega-3 carboxylic acids)
- corn oil control
-
Birmingham, Alabama
- +684 more
Aug 16, 2021
Anemia, End Stage Renal Disease (ESRD) Trial in Worldwide (Roxadustat, Epoetin alfa, Darbepoetin alfa)
Completed
- Anemia
- End Stage Renal Disease (ESRD)
- Roxadustat
- +3 more
-
Brussels, Flemish Brabant, Belgium
- +142 more
Jan 14, 2021
Lymphangioleiomyomatosis Trial in Boston ("Sirolimus" and "Hydroxychloroquine" 200 mg, "Sirolimus" and "Hydroxychloroquine" 400
Completed
- Lymphangioleiomyomatosis
- "Sirolimus" and "Hydroxychloroquine" 200 mg
- "Sirolimus" and "Hydroxychloroquine" 400 mg
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 13, 2018
Type 2 Diabetes Trial (Omarigliptin, Placebo to Omarigliptin, Glimepiride)
Study: Renal Manifestations
Completed
- Tuberous Sclerosis Complex
-
Cincinnati, OhioCincinnati Children's
May 2, 2017
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
CT-P13 For Standard Of Care Treatment Of Inflammatory Bowel
Completed
- Inflammatory Bowel Diseases
- +2 more
-
Leuven, Vlaams Brabant, Belgium
- +139 more
Jan 30, 2020
Coronary Artery Disease Trial in Worldwide (PROMUS Coronary Stent System, PROMUS Element Coronary Stent System, Aspirin)
Completed
- Coronary Artery Disease
- PROMUS Coronary Stent System
- +3 more
-
Birmingham, Alabama
- +132 more
Mar 13, 2019
Infections, Papillomavirus Trial in China (HPV GSK 580299 vaccine, Placebo control)
Completed
- Infections, Papillomavirus
- HPV GSK 580299 vaccine
- Placebo control
-
Jintan, Jiangsu, China
- +3 more
May 3, 2019
Iron Deficiency Anemia, Impaired Renal Function Trial in Norristown (Ferric Carboxymaltose (FCM), Iron Sucrose (Venofer))
Completed
- Iron Deficiency Anemia
- Impaired Renal Function
- Ferric Carboxymaltose (FCM)
- Iron Sucrose (Venofer)
-
Norristown, PennsylvaniaLuitpold Pharmaceuticals, Inc.
Jan 22, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Herpes Zoster Trial in Worldwide (Herpes Zoster vaccine GSK1437173A Low Dose, Herpes Zoster vaccine GSK1437173A Medium Dose,
Completed
- Herpes Zoster
- Herpes Zoster vaccine GSK1437173A Low Dose
- +4 more
-
Hradec Kralove, Czechia
- +10 more
Feb 22, 2019
Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,
Completed
- Diabetes Mellitus, Type 2
- +2 more
- Placebo
- +2 more
-
Birmingham, Alabama
- +312 more
Nov 5, 2018
Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)
Completed
- Cardiovascular Disease
-
Decatur, Georgia
- +202 more
Jun 12, 2018
Adrenocortical Adenoma, Endometrial Stromal Sarcomas Trial in Worldwide (MRI, CT or ultrasound was permitted if MRI was
Completed
- Adrenocortical Adenoma
- Endometrial Stromal Sarcomas
- MRI, CT or ultrasound was permitted if MRI was contraindicated
- +4 more
-
Tallahassee, Florida
- +19 more
Oct 24, 2016
MDD Trial in Worldwide (LY2216684, Placebo, SSRI)
Migraine Disorders Trial in Australia, Korea, Republic of, United States (onabotulinumtoxinA)
Completed
- Migraine Disorders
- onabotulinumtoxinA
-
Scottsdale, Arizona
- +31 more
Nov 9, 2016
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (fluticasone furoate/vilanterol, fluticasone furoate, vilanterol)
Completed
- Pulmonary Disease, Chronic Obstructive
- fluticasone furoate/vilanterol
- +3 more
-
Andalusia, Alabama
- +1620 more
Aug 2, 2018
Lymphangioleiomyomatosis, Tuberous Sclerosis Trial in Nottingham (Doxycycline, Placebo)
Completed
- Lymphangioleiomyomatosis
- Tuberous Sclerosis
- Doxycycline
- Placebo
-
Nottingham, United KingdomNottingham University Hospitals
Dec 1, 2015